These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 25022261)
41. Rare Germline Martínez de LaPiscina I; Hernández-Ramírez LC; Portillo N; Gómez-Gila AL; Urrutia I; Martínez-Salazar R; García-Castaño A; Aguayo A; Rica I; Gaztambide S; Faucz FR; Keil MF; Lodish MB; Quezado M; Pankratz N; Chittiboina P; Lane J; Kay DM; Mills JL; Castaño L; Stratakis CA Front Endocrinol (Lausanne); 2020; 11():433. PubMed ID: 32714280 [No Abstract] [Full Text] [Related]
42. Lack of pathogenic germline DICER1 variants in males with testicular germ-cell tumors. Vasta LM; McMaster ML; Harney LA; Ling A; Kim J; Harris AK; Carr AG; Damrauer SM; Rader DJ; Kember RL; Kanetsky PA; Nathanson KL; Pyle LC; Greene MH; Schultz KA; Stewart DR; Cancer Genet; 2020 Oct; 248-249():49-56. PubMed ID: 33158809 [TBL] [Abstract][Full Text] [Related]
43. Childhood Rhabdomyosarcoma of the Female Genital Tract: Association with Pathogenic DICER1 Variation, Clinicopathological Features, and Outcomes. Kebudi R; Dural O; Bay SB; Gorgun O; Onder S; Bilgic B; Yilmaz I; Iribas A; Arndt CA; Harris AK; Field A; Schultz KAP; Hill DA J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):449-453. PubMed ID: 33484847 [TBL] [Abstract][Full Text] [Related]
44. A complex DICER1 syndrome phenotype associated with a germline pathogenic variant affecting the RNase IIIa domain of DICER1. Pontén E; Frisk S; Taylan F; Vaz R; Wessman S; de Kock L; Pal N; Foulkes WD; Lagerstedt-Robinson K; Nordgren A J Med Genet; 2022 Feb; 59(2):141-146. PubMed ID: 33208384 [TBL] [Abstract][Full Text] [Related]
45. Nasal chondromesenchymal hamartomas arise secondary to germline and somatic mutations of DICER1 in the pleuropulmonary blastoma tumor predisposition disorder. Stewart DR; Messinger Y; Williams GM; Yang J; Field A; Schultz KA; Harney LA; Doros LA; Dehner LP; Hill DA Hum Genet; 2014 Nov; 133(11):1443-50. PubMed ID: 25118636 [TBL] [Abstract][Full Text] [Related]
46. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors. de Kock L; Terzic T; McCluggage WG; Stewart CJR; Shaw P; Foulkes WD; Clarke BA Am J Surg Pathol; 2017 Sep; 41(9):1178-1187. PubMed ID: 28654427 [TBL] [Abstract][Full Text] [Related]
47. On the Chopping Block: Overview of DICER1 Mutations in Endocrine and Neuroendocrine Neoplasms. Juhlin CC Surg Pathol Clin; 2023 Mar; 16(1):107-118. PubMed ID: 36739158 [TBL] [Abstract][Full Text] [Related]
48. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors. Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933 [TBL] [Abstract][Full Text] [Related]
49. The Value of DICER1 Mutation Analysis in "Subtle" Diagnostically Challenging Embryonal Rhabdomyosarcomas of the Uterine Cervix. Yoon JY; Apellaniz-Ruiz M; Chong AL; Slim Z; Salfinger SG; Clarke BA; Stewart CJR; Foulkes WD; McCluggage WG Int J Gynecol Pathol; 2021 Sep; 40(5):435-440. PubMed ID: 33021556 [TBL] [Abstract][Full Text] [Related]
50. Structural renal abnormalities in the DICER1 syndrome: a family-based cohort study. Khan NE; Ling A; Raske ME; Harney LA; Carr AG; Field A; Harris AK; Williams GM; Dehner LP; Messinger YH; Hill DA; Schultz KAP; Stewart DR Pediatr Nephrol; 2018 Dec; 33(12):2281-2288. PubMed ID: 30178239 [TBL] [Abstract][Full Text] [Related]
51. DICER1 pleuropulmonary blastoma familial tumour predisposition syndrome: What the paediatric urologist needs to know. Faure A; Atkinson J; Bouty A; O'Brien M; Levard G; Hutson J; Heloury Y J Pediatr Urol; 2016 Feb; 12(1):5-10. PubMed ID: 26454454 [TBL] [Abstract][Full Text] [Related]
52. An update on the central nervous system manifestations of DICER1 syndrome. de Kock L; Priest JR; Foulkes WD; Alexandrescu S Acta Neuropathol; 2020 Apr; 139(4):689-701. PubMed ID: 30953130 [TBL] [Abstract][Full Text] [Related]
53. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage. Anglesio MS; Wang Y; Yang W; Senz J; Wan A; Heravi-Moussavi A; Salamanca C; Maines-Bandiera S; Huntsman DG; Morin GB J Pathol; 2013 Feb; 229(3):400-9. PubMed ID: 23132766 [TBL] [Abstract][Full Text] [Related]
54. Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing platform. Ghossein CA; Dogan S; Farhat N; Landa I; Xu B Virchows Arch; 2022 Feb; 480(2):293-302. PubMed ID: 34580763 [TBL] [Abstract][Full Text] [Related]
55. DICER1 RNase IIIb domain mutations are infrequent in testicular germ cell tumours. de Boer CM; Eini R; Gillis AM; Stoop H; Looijenga LH; White SJ BMC Res Notes; 2012 Oct; 5():569. PubMed ID: 23068969 [TBL] [Abstract][Full Text] [Related]
56. Ovarian embryonal rhabdomyosarcoma is a rare manifestation of the DICER1 syndrome. de Kock L; Druker H; Weber E; Hamel N; Traubici J; Malkin D; Arseneau J; Stewart CJ; Bouron-Dal Soglio D; Priest JR; Foulkes WD Hum Pathol; 2015 Jun; 46(6):917-22. PubMed ID: 25836323 [TBL] [Abstract][Full Text] [Related]
57. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry. Schultz KA; Pacheco MC; Yang J; Williams GM; Messinger Y; Hill DA; Dehner LP; Priest JR Gynecol Oncol; 2011 Aug; 122(2):246-50. PubMed ID: 21501861 [TBL] [Abstract][Full Text] [Related]
58. Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations. Chernock RD; Rivera B; Borrelli N; Hill DA; Fahiminiya S; Shah T; Chong AS; Aqil B; Mehrad M; Giordano TJ; Sheridan R; Rutter MM; Dehner LP; Foulkes WD; Nikiforov YE Mod Pathol; 2020 Jul; 33(7):1264-1274. PubMed ID: 31937902 [TBL] [Abstract][Full Text] [Related]
59. Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin-like enhancer 1 in primary intracranial sarcoma, DICER1-mutant. Alexandrescu S; Meredith DM; Lidov HG; Alaggio R; Novello M; Ligon KL; Vargas SO Histopathology; 2021 Jan; 78(2):265-275. PubMed ID: 32692439 [TBL] [Abstract][Full Text] [Related]